Pharmacy Automation Systems Increasing R&D Projects to Spell Growth of the Market

Future Market Insights delivers key insights and presents a revised forecast of the global Pharmacy Automation Systems market for a 10-year period from 2017 to 2027 in the report titled “Pharmacy Automation Systems Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027.” The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of key market participants. The global pharmacy automation systems market is projected to expand at a healthy CAGR of 6.3% in terms of value during the forecast period, revised from the previous CAGR of 6.7%, due to factors such as adoption of automatic dispensing cabinets and other product types across the globe, regarding which FMI offers useful insights in detail in this report.

Request a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5079

Segmental Forecast

The market has been segmented based on product type, application, end user and regions. Based on product type, the market is segmented into medication dispensing cabinets or automated dispensing cabinets, packaging and labelling systems, IV pharmacy (automated drug compounding), robotic dispensing systems, carousal storage systems and tablet splitters. Automated dispensing cabinets are expected to grow at the fastest CAGR due to increase in the usage of these systems for decentralised pharmacies and point of care settings. The segment is expected to register a CAGR of 7.4% during the forecast period. However exorbitant costs for the implementation of pharmacy automation systems is expected to adversely affect demand for these systems in the near future.

To provide deeper insight into the pattern of demand for pharmacy automation systems, the market has been segmented based on the application of these systems such as drug dispensing & packaging, drug storage and inventory management. The inventory management application segment is expected to expand at the highest CAGR of 7.6% over the forecast period due to increasing demand for these systems to track and maintain inventory levels in pharmacies.

To analyse the sales of pharmacy automation systems further, the market has been segmented based on end users such as hospital pharmacies, clinic pharmacies, retail pharmacies, mail order pharmacies and pharmaceutical SMEs. Pharmaceutical SMEs is expected to present the highest demand for pharmacy automation systems over the forecast period, registering a CAGR of 7.8% and this is attributed to gradual increase in the number of SMEs or companies maintaining centralized pharmacies.

A key trend in the pharmacy automation systems market is the increasing usage of RFID enabled automated dispensing cabinets. Also, key players in this market are increasingly working on big data and analytics solutions to provide useful and valuable insights to their clients.

Ask an Analyst: https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5079

This report assesses the trends driving growth of each segment at the global as well as regional levels, and offers potential takeaways that could prove substantially useful to pharmacy automation systems companies looking to enter the global market. It also provides insights into different factors for vendor selection criteria that might be useful for companies to make strategic decisions regarding their marketing plans. North America dominated the pharmacy automation systems market with maximum value share in 2016. North America and Western Europe collectively accounted for more than 80% of the total pharmacy automation systems market share in terms of value in 2016. Among emerging markets, Asia Pacific excluding Japan is estimated to exhibit the highest CAGR of 7.8% over the forecast period, due to increase in the need for automation solutions to better manage crowds in hospitals and retail pharmacies.

Key Players

Some key players in the global pharmacy automation systems market identified in the report include Baxter International Inc., Swisslog Holdings AG, Care Fusion Corporation, Cerner Corporation, Kirby Lester LLC, Omnicell Inc. etc. We have discussed individual strategies of these companies in terms of enhancing the product portfolio, distribution partnerships, market consolidation and advanced R&D initiatives. In addition to this the report also provides company share and a competitive dashboard for players already present in the market.

Request Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-5079

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Neonatal Phototherapy Devices Market Insights, New Innovations, Research and Growth Factor till 2032

The World Health Organization estimated in 2015 that 4/5th of preterm infants developed jaundice. Preterm birth rates can be as high as 7% in developed countries and are even higher in developing ones. Babies with neonatal jaundice are far more likely to develop hyperbilirubinemia that can lead to neurological damage or even premature death. The National Institute of Health journal estimated that healthcare cost linked to preterm American births in terms of lost efficiency and medical expenditure were more than US$ 26 billion in 2005 itself. APAC and Africa had the unfortunate distinction of accounting for more than 80% of all preterm births in 2005, making infants there vulnerable to neonatal jaundice. Therefore, neonatal phototherapy treatment is the need of the hour.

Get a Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5064

Technological advancements in monitoring and phototherapy devices

Rapid technological innovations are predicted to favour companies investing in user-friendly control panel phototherapy devices and blue spectrum radiation sources. Key stakeholders are working on LED radiation sources as they can optimally control radiation intensity and have consume a minimal amount of power. Companies in the neonatal phototherapy devices market are focusing on devices with a peak wavelength of 460 nm and which can be mounted on an incubator or a warmer to avoid infrared and ultraviolet radiation. The primary drivers of growth in the neonatal phototherapy devices market are the high frequency of neonatal jaundice, rising demand for effective neonatal jaundice treatment and management, and a greater awareness of the existence of such procedures.

Home-based phototherapy actively promoted to create huge opportunities

The largest end-user in the neonatal phototherapy devices market is undoubtedly hospitals and NICU’s. However, the high treatment cost and lack of adequate phototherapy units at the vast majority of neonatal phototherapy centres have assisted the growth of home-based phototherapy units. Home-based phototherapy units have several advantages such as reduced patient hassle, transportation cost, and hospital waiting time. Furthermore, home-based phototherapy reduces both direct and indirect healthcare costs and improves the mother-infant bonding. An article published in the U.S. National Library of Medicine stated that approx. US$ 18,000 was saved by a little over 60 infants in their homes as opposed to hospitals and there were no reported side-effects.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5064

Product differentiation a challenge in the neonatal phototherapy devices market

The uptake of neonatal phototherapy devices is minimal in low and medium income countries. Most revenue in the neonatal phototherapy devices market is generated in developed economies, their low birth rates notwithstanding. The North America neonatal phototherapy devices market is poised to grow to more than US$ 36 million in 2027 with the U.S alone approaching US$ 35 million. The main reason for this is the lack of product development in the neonatal phototherapy devices market. There have been several cases where neonatal phototherapy devices have failed and been recalled by the FDA, hampering revenue growth during the forecast period. For e.g. – In December 2016, the NeoBlue Blanket LED Phototherapy System was recalled by the FDA because of device degradation following the melting of its fibre optic cable.

High prices stifle adoption in the neonatal phototherapy devices market

Neonatal phototherapy devices are extremely expensive making affordability a critical issue in emerging economies as hospitals there often have limited funds and cannot afford to maintain such equipment. A Stanford study said that many hospitals in Nigeria and India were unable to source an average of six phototherapy bulbs that cost roughly US$ 15 per bulb as they needed to be replaced every four months. The APAC neonatal phototherapy devices market is anticipated to be valued at more than US$ 4 million by end 2027. Thus, companies need to try to make their neonatal phototherapy devices cost-effective and governmental support will also go a long way in boosting the prospects of the neonatal phototherapy devices market in emerging economies.

Get Full Report from here: https://www.futuremarketinsights.com/checkout/5064

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Medical Carts Market is expected to surge at a CAGR of 7.8% to reach US$ 5.3 Bn by 2028 | FMI

[170 Pages Report] The global Medical Carts Market is slated to enjoy a valuation of US$ 3.4 Bn in 2022, and is predicted to surge at a CAGR of 7.8% to reach US$ 5.3 Bn by the end of 2028.

Growing need for quick access to mobile electronic health records at the point of care has led to surge in demand for medical carts globally. In addition, increasing demand for improving operational efficiency in the healthcare industry is projected to impact the global market growth of medical carts positively. Future Market Insights states that the global market of medical carts is projected to reflect a CAGR of 11.0% over the forecast period, 2022-2028.

Request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2807

Factors Fuelling the Global Market Growth

Growth of the global medical carts market is mainly bound to various macro-economic and micro-economic factors. As the need for accessing medical records at the point of care continues to increase, mobile healthcare technology is projected to witness significant adoption. Growing concerns regarding healthcare expenditure has further led the manufacturers to develop mobile technology carts for the outpatient facilities, large academic medical centers, and acute care centers. Adoption of medical carts equipped with technological features allows the end users to retrieve and store information to enhance patient safety. In addition, medical carts allows the end users to spend less time worrying about the technology and offer better services to the patients in the hospitals.

In order to offer ease of movement to the end users, the healthcare manufacturers are increasingly focusing on designing medical carts. Bad design elements include sharp edges in medical carts along with wheel design that impedes navigation and results in ineffective performance. In addition, inability to adjust the height of cart and lack of battery power indicator can also pose significant challenges for the end users while conducting an operation. Increasing demand for medical carts designed with ergonomics will further contribute towards the global market growth of medical carts over the forecast period.

Adoption medical carts allows the caretakers to accommodate computers that can conveniently be accessed to perform multiple operations in the healthcare setup. As medical carts are incorporated with battery systems medically approved by FDA along with wireless technology, healthcare professionals and caretakers can conveniently access, store and retrieve the patient information in the clinics and hospitals. In addition, adoption of medical carts in various healthcare institutes has lowered the healthcare expenditure and also saves space. These factors are expected to impact the global market growth of medical carts positively throughout the forecast period.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2807

Market Players

  • InterMetro Industries Corporation
  • Omnicell Inc.
  • Capsa Solutions Llc
  • Armstrong Medical Industries Inc.
  • Midmark Corporation
  • Medline Industries Inc.
  • ITD GmbH
  • The Bergmann Group
  • Ergotron Inc.
  • Jaco Inc.
  • AFC Industries Inc.

Sales to Remain High for Computer Medical Carts

Growing need to access the health records of patients at the point of care has led to surge in demand for computer medical carts in the healthcare industry. In terms of revenue, the computer medical carts product type segment is projected to represent the highest growth, recording more than US$ 1,800 Mn by 2028-end. On the other hand, the other product type segment is projected to reflect the fastest growth in the global market over the forecast period.

By 2022-end, the hospitals end users segment is projected to generate significant revenues, accounting for more than US$ 800 Mn. In contrary, the diagnostic centres end users segment is projected to reflect the highest CAGR throughout 2028.

Based on energy source, the non-powered segment is projected to witness a robust revenue growth, recording for more than US$ 3,100 Mn by 2028-end. On the other hand, the powered energy source segment is projected to reflect a significant CAGR over the forecast period.

During the forecast period, the plastic material type segment is projected to reflect the fastest growth in the global market of medical carts. However, the metal material type segment is projected to represent a robust revenue growth, accounting for around US$ 1,300 Mn by 2022-end.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2807

Key Segments of Medical Carts Industry Survey

By Medical Carts Market by Product Type:

  • Emergency Carts
  • Procedure Carts
  • Anaesthesia Carts
  • Computer Medical Carts
  • Other Product Types

By Medical Carts Market by End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centres
  • Other End Users

By Medical Carts Market by Material Type:

  • Metal Medical Carts
  • Plastic Medical Carts
  • Wooden Medical Carts

By Medical Carts Market by Energy Source:

  • Powered Medical Carts
  • Non-Powered Medical Carts

By Medical Carts Market by Region:

  • North America Medical Carts Market
  • Latin America Medical Carts Market
  • Europe Medical Carts Market
  • East Asia Medical Carts Market
  • South Asia & Pacific Medical Carts Market
  • Middle East & Africa (MEA) Medical Carts Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Tourism Market is expected to reach a valuation of US$ 6.7 Billion in 2022 | FMI

The global dental tourism market is primarily driven by increasing cases of dental defects and an increasing preference for cosmetic dentistry worldwide. Lower treatment price and better service in dental treatment abroad, long waiting times at home for dental treatment can stimulate the growth of the market in the near future. Dentist malpractice is likely to hold back the market during the forecast period.

DUBAI, United Arab Emirates, May 9, 2022 (GLOBE NEWSWIRE) — The global dental tourism market is expected to reach a valuation of US$ 6.7 bn in 2022, with sales growth of a 13.6% CAGR during the forecast period. Rapid adoption of technologically advanced medical devices in emerging economies will drive the growth in the market, with the market size reaching € 24.3 bn by 2032.

Rising costs of health care and dental services in developed countries are forcing consumers to adopt dental tourism. This trend is driven by the lack of insurance coverage for major elective dental surgery procedures in several countries.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14623

In addition, treatment costs in countries such as India, Thailand and China are relatively lower than in the countries of North America and Europe. This reflects an increase in dental tourism from Europe and North America to emerging economies. Obtaining a medical visa for such procedures is comparatively faster and easier, thereby facilitating the flow of patients abroad for treatment.

Promotional strategies such as the launch of online campaigns showcasing cost-effective services from healthcare facilities are contributing to the growth of the market. Providing undivided attention to healthcare and providing affordable accommodation sparks consumer interest in adopting attractive medical-tourism packages, identifying both treatment and recreational choices.

With increasing lifestyle-related diseases and unhealthy dietary intake, the incidence of dental disease is increasing. High prevalence of diseases such as dental caries has led to a spike in dental restoration procedures. Thus, the increasing burden of dental abnormalities is propelling the interest in cosmetic dentistry, creating growth opportunities in the market.

“Increasing adoption of technologically advanced medical devices in emerging economies, along with increasing government-backed investment in the The development of healthcare infrastructure in these countries is expected to drive the market in the coming years,” said an FMI analyst.

Key learning points:

  • On a services basis, revenue in the dental cosmetics segment will grow at a robust CAGR of 18.1% through 2032.
  • In terms of providers, the hospital chain segment is expected to account for 47.2% of the total market share by 2022.
  • India will emerge as a lucrative pocket, accounting for 53.9% of the dental tourism market share in South Asia by 2022.
  • What are some of the core competencies and differentiating competencies of new entrants and established players in the industry that we analyze?
  • What are some of the brand opportunities that are developing at a rapid pace?
  • What are the key competitive forces and elements of the external environment that determine the industry lifecycle stages of most organizations?
  • Why are some competitive strategies more popular than others among leaders in a particular market?
  • What customer-based brand value strategies have companies used in a particular industry or set of related industries in an industry?

Ask for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14623

Competition landscape

With the advancement in cosmetic dentistry, market players are striving to offer these services at affordable prices to gain a competitive advantage. They also invest in mergers, acquisitions and collaborations to expand their global presence. Other strategies include product and service promotions on social media and online channels, as well as partnerships with hospital chains.

Key Market Segments Covered in Dental Tourism Industry Research

By services:

  • Dental implants
  • Periodontology
  • endodontics
  • Dental prostheses
  • Orthodontics
  • pedodontics
  • Oral surgery
  • Dental Cosmetics
  • Dental Consultation

By travelers:

  • Occasional travelers
  • Business travelers

By providers:

  • Hospital chains
  • Multi-Specialty Clinics
  • Independent clinics

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/14623

Index
1. Summary

1.1. Global Market Outlook

1.2. Demand-side trends

1.3. Supply-side trends

1.4. Technology roadmap analysis

1.5. Analysis and recommendations

  1. Market overview

2.1. Market coverage/taxonomy

2.2. Market Definition / Scope / Restrictions

  1. Market Background

3.1. Market dynamics

3.1.1. drivers

3.1.2. limits

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in optimistic scenario

3.2.2. Ask in likely scenario

3.2.3. Question in conservative scenario

  1. Global Dental Tourism Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Expenditure Analysis (US$ Billion), 2017-2021

4.2. Current and Future Expenditure Projections (US$ Billion), 2022-2032

4.2.1. YoY Growth Trend Analysis

4.2.2. Absolute $Opportunity Analysis

  1. Global Dental Tourism Market Analysis 2017-2021 and Forecast 2022-2032, By Services

5.1. Introduction / Key Findings

5.2. Analysis of historical spend (US$ billion) by services, 2017-2021

5.3. Analysis of Current and Future Expenses (US$ Billion) and Forecast by Services, 2022-2032

TOC Continue…

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Branded Generics Market Analysis, Recent Trends and Regional Growth Forecast by 2027

[280 Pages Report] ESOMAR-certified consulting firm Future Market Insights (FMI) in its latest report forecasts that the global branded generics market will register healthy growth at a CAGR of 5.8% between 2021 and 2031.

The swift growth of branded generics market can be attributed to the growing number of patent expiry of branded or blockbuster drugs along with increasing prevalence of chronic diseases. Rising demand for cheap medical treatments is positively impacting the demand in the market.

Branded generics are pharmaceutical drugs that have been re-released with a different brand name. They are used to treat various diseases such as diabetes, hypertension, back pain and others. These drugs occupy small but lucrative subset of the entire generic market

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

Since branded generics are free from patenting, companies are investing handsome amounts on this drug category. The market is set to reach a valuation of around 283.2 Bn in 2021, with top players in tier-1 accounting for 20%-25% market share.

The entry of new players, simple market authorization procedures, greater profit margin and off-invoice discounts will expand branded generics market during the forecast period.

As per the FMI’s analysis, despite the slight setback due to the pandemic, the global branded generics market registered year-on-year (Y-o-Y) growth at 4.9% CAGR during 2020-2021.

“Rising demand for branded generics across both developing and developed economies along with high penetration of pharmaceutical industry will offer lucrative growth opportunities for the branded generics manufacturers during the forecast period” says the FMI analyst.

Key Takeaways from FMI’s Branded Generics Market Study

  • China and India are spearheading the growth of Asia Pacific market spurred by the increasing adoption of branded generics by large-scale pharmacy chains in the emerging economies
  • The U.S. will lead the North America’s branded generics market, registering a growth at 3.83% CAGR during the forecast period.
  • The market in India is expected to offer lucrative growth opportunities to branded generics manufacturers backed the expansion of pharmaceutical industry
  • In terms of therapeutic application, cardiovascular diseases and diabetes are expected to account for considerable market share
  • Oral solid dose pharmaceutical formulation continues to be highly preferred among patients. The oral segment accounts for over 55% share of the global branded generics market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1260

Competitive Landscape

Teva, Abbott Laboratories, Novartis, Mylan, Pfizer are some prominent players operating in the branded generics market cumulatively hold around 20-25% market share.

Key players operating in branded generic market are focusing on expanding their business in emerging markets. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

  • In October 2020, Glenmark Pharmaceuticals, introduces NINDANIB (Nintedanib) for the treatment of pulmonary fibrosis in India. Glenmark has been amongst the first to launch the branded generic version at an affordable cost for the treatment of pulmonary fibrosis in India.

More Valuable Insights on Branded Generics Market

In its latest report, FMI provides an incisive coverage on the global branded generics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031.The study provides compelling insights on branded generics market on the basis of therapeutic application (oncology, cardiovascular diseases, diabetes, neurology, gastro intestinal diseases, dermatology diseases, analgesic and others), drug class (alkylating agents, anti-metabolites, hormones, anti-hypertensives, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics and others ), formulation type (oral, parenteral, topical, others) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, drug stores) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1260

Branded Generics Market by Category Therapeutic Application:

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Dermatology Diseases
  • Analgesics and Anti-inflammatory
  • Others

Drug Class:

  • Alkylating Agents
  • Antimetabolites
  • Hormones
  • Anti-Hypertensive
  • Lipid Lowering Drugs
  • Anti-Depressants
  • Anti-Psychotics
  • Anti-Epileptics
  • Others

Formulation Type:

  • Oral
  • Parenteral
  • Topical
  • Others

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Laboratories Market is set to witness substantial growth at a CAGR of about 5.6% from 2022 to 2032

[107 Pages Report] According to the latest revised industry analysis from Future Market Insights, the global dental laboratories Market but was valuable US Dollar$ 29.24 Bn Expected to exhibit close CAGR in 2021 5.6, Over the forecast period (2022-2032).

In restorative dentistry, the major responsibility of the dental laboratory is to accurately reproduce all the functional and aesthetic requirements that the dentist has established in a restorative solution. Increase in dental tourism and medical operations as a result of attractive marketing approaches affecting the cosmetic appeal of dental integrity. This has influenced the global expansion of the dental laboratories market.

Dental laboratories have seen rapid improvement in terms of the structural structure of operations as well as the process flow of the dental practice. These advancements include rapid digitization, integrated artificial intelligence and the Internet of Things (IoT) within standard dental workflows and procedures. This standard facilitates the adoption of a time-efficient and cost-effective approach to personalized therapeutic interventions by adding personalized effects to the procedural flow.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14651

Additionally, advances in implant materials, such as the use of hydroxyapatite coatings and bone morphogenic proteins, have resulted in painless procedures with shorter chair times and faster healing.

With the introduction of CAD/CAM to accelerate the process of planning and management of complex dental procedures and implant design through 3D imaging, dental laboratories are moving towards better patient diagnosis.

Due to rising incidence of periodontal diseases, high prevalence rate of elderly population, unhealthy dietary practices due to increasing lifestyle changes, high tobacco consumption and recent wave of industrial automation, the dental laboratories market is expected to witness a profitable growth . Rate.

Key Takeaways From Market Study

  • Depending on the equipment, the Systems & Parts segment is expected to hold 35, Global market value share through 2022 and beyond.
  • In terms of product, the implant had a major market share value 28.3% In the global market of 2021.
  • North America is considered the leading region with a price share of 36.4% in 2021.
  • US is expected to lead the growth in the North America Dental Lab market during the forecast period

,advanced Systems within automated dental laboratories will promote smooth procedural workflows with less manual intervention. Hence, major players in dental laboratories are offering advanced and automated dental equipment to gain revenue,, Says an analyst at Future Market Insights.

Browse Detailed Summary Research report with TOC @ https://www.futuremarketinsights.com/reports/dental-laboratories-market

Market Competition

The dental laboratory market exhibits a number of promotional activities that have an impact on the growth of the market and the regional footprint expansion of the major players. The process of systems and technology up-gradation, as well as integration of digital and telehealth solutions into the common procedural flow, are all part of these operations.

For Example:

  • In December 2021, Septodont Holdings completed its deal with Sanofi to purchase the dental brands Birodogyl®, Ultracain®, Dontisolon®, and Rodogyl®, as well as related medical equipment.
  • Ivoclar Vivadent announced in November 2021 a new and revolutionary version of its Programat® furnaces, introducing the Internet of Things to the modern dental laboratory system.

Want more insight?

Future Market Insights brings to you a comprehensive research report on projected revenue growth at global, regional and country levels and provides analysis of the latest industry trends in each sub-segment from 2017 to 2032. The global Dental Laboratories market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. This study provides compelling insight into the dental laboratories market segment on the basis of product (resurrection, orthodontic, endodontic, implant and oral care) and equipment (dental radiology equipment, dental lasers, systems and parts, laboratory machines, hygiene maintenance equipment, and others) provides. ) in seven major regions of the world.

For a complete research report @ https://www.futuremarketinsights.com/checkout/14651

The major players involved in the f Dental Laboratories Market are:

  • Envista Holdings Corporation
  • Dentsply Sirona
  • A-Dec Inc.
  • Strowman AG
  • Danaher Corporation
  • Zimmer Biomet Holdings, Inc.
  • Ultradent Products, Inc.
  • GC Corporation
  • Mitsui Chemicals, Inc.
  • Planmeca Oy
  • Bego GmbH & Co. Kg
  • Septodont Holding
  • Evocolor Vivadent AG
  • Henry Schein, Inc.
  • Champlain Dental Laboratory, Inc.
  • knight dental design
  • National Dentex Corporation
  • 3M Health Care

Detailed Table of Contents:

  • executive Summary
    • Global Market Outlook
    • demand side trends
    • supply side trends
    • technology roadmap
    • analysis and recommendations
  • market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Boundaries
    • Inclusions and Exclusions
  • major market trends
    • Major trends affecting the market
    • Product Innovation / Development Trends
  • market background
    • macro-economic factors
      • Global GDP Growth Outlook
      • Global Health Care Expenditure Outlook
      • Development of healthcare sector in emerging countries
    • Predictive Factors – Relevance and Impact
      • increase in technological progress
      • strategic cooperation
      • Product launch frequency
      • Increase in health care spending in developing economies
    • market dynamics
      • drivers
      • Helplessness
      • opportunity analysis
  • COVID19 Crisis Analysis
    • COVID19 and Impact Analysis
      • revenue by equipment
      • Income by Product Type
      • revenue by region
    • 2021 Market Scenario
  • critical success factors
    • Product Adoption/Usage Analysis
    • Key Promotional Strategies by Major Manufacturers
    • regulatory landscape
    • reimbursement scenario
    • value chain analysis
    • Porter’s analysis
    • pastel analysis

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Endovenous Laser Therapy Market is projected to reach US$ 811.0 Million by 2031 | FMI

[151 Pages Report] According to a recent study by Future Market Insights (FMI), the global endovenous laser therapy market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 378.3 Mn in 2021 to over US$ 811.1 Mn by 2031. This reflects a cumulative CAGR of around 7.9% over the forecast period (2022-2031).

Rise in number of varicose veins cases, availability of technologically advanced laser therapy, shift towards minimally invasive procedures and increasing product launches are the primary factors responsible for the growth of the market during the forecast period.

Request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2785

Varicose veins are more common in pregnant women, partially because the baby puts more pressure on the veins and partly because hormones generated during pregnancy relax vein walls. Varicose veins can develop as a result of damage to a deep leg vein. Over the projected period, rising instances of varicose veins are expected to drive revenue growth in the endovenous laser systems market.

Another factor that is having a positive impact on endovenous laser therapy is the rapid change in lifestyle with no physical activity and labour across the globe, as well as the rise in the elderly population, both of which are anticipated to contribute to the global market’s growth over the forecast period. The market is also expected to develop due to the quick and effective technique as well as the growing demand for endovenous laser therapy.Moreover, growing prevalence of obesity worldwide is driving growth of the endovenous laser therapy market. Obesity leads to problems related to blood circulation which leads to varicose veins.

Medical device manufacturers operating in the endovenous laser therapy market are focusing on providing user friendly devices to the end users to minimize chances of manual errors. In addition, continuous launch of new and improved products and increasing investment in research and development by the manufacturers in endovenous laser therapy devices would lead to growth of global market over the forecast period.

Key Takeaways from Endovenous Laser Therapy Market Study

  • Endovenous laser systems held the maximum share of 92.0% in 2021 by component, expanding at a rapid rate owing to the rising number of varicose veins cases and increase in number of product launches with advanced features.
  • Ambulatory surgical centers showed maximum growth among all end users with a market share of 36.2% in 2021 owing to the rise in demand for outpatient surgeries. In countries such as the U.S., endovenous laser therapy for varicose veins is majorly performed in ambulatory surgical centers rather than hospitals in order avoid long-time waiting in big hospital settings, which is why the segment is developing at a rapid rate
  • North America held the largest share of 42.7% of the global endovenous laser therapy market by region in 2021 indicating the growth due to increase in prevalence of obesity and growing number of FDA approvals in North America.

“Growing prevalence of varicose veins, shift towards minimally invasive procedures, availability of novel laser treatment and increasing number of product launches Is Expected to Drive the Demand for Endovenous Laser Therapy over the Decade,” says the FMI Analyst

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2785

Who is winning?

The key market players covered by FMI include AngioDynamics, Inc., Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, Wontech Co., Ltd., intros Medical Laser GmbH and Energist Ltd.

Some of the leading manufacturers of endovenous laser therapy market are focusing on product launch, approvals, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

  • In January 2021, Syneron Medical Ltd. announced the availability of the Frax Pro™ system. The FDA-cleared and CE-marked, non-ablative fractional device is the first platform featuring dual-depth skin resurfacing with both Frax 1550™ and the novel Frax 1940™ applicators.
  • In July 2020, Wontech announced that ‘Picowon’, an alexandrite (755nm)-based pico laser, has obtained US Food and Drug Administration (FDA) approval for the first time in Asia and the second in the world.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global endovenous laser therapy market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on endovenous laser therapy segment based on product (Endovenous Laser Systems {Diode Lasers and YAG Lasers}, and Endovenous laser Fibers {Bare Tip Laser Fiber, Radial Tip Laser Fiber and Gold Tip Laser Fiber}), and end user (hospitals, ambulatory surgical centers and Specialized Clinics) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2785

Endovenous laser therapy Market by Category By Product

  • Endovenous Laser Systems
    • Diode Lasers
    • Yag Lasers
  • Endovenous Laser Fibers
    • Bare Tip Laser Fibers
    • Radial Tip Laser Fiber
    • Gold tip Laser Fiber

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Biotherapeutics Virus removal filters Market is projected to be valued at US$ 424.3 Million in 2022 | FMI

The increasing investment by the government is the major role for better healthcare is expected to drive the market. The companies are engrossed in introducing the products for combat dressing. The biotherapeutics virus removal filters market is classified by technology, application and end user. In terms of technology, the global market of biotherapeutics virus removal filters is divided into size exclusion technology and depth filtration technology. By application the biotherapeutics virus removal filters market is segmented as monoclonal antibodies, blood & plasma, enzymes and protein. By end user, the biotherapeutics virus removal filters market is segmented into biopharmaceutical companies, clinical research organizations, academic institutes and others. Among all end user, biopharmaceutical companies are expected to gain maximum value share over the forecast period.

Biotherapeutics Virus removal filters Market Overview

The biotherapeutics virus removal filters provide robust and economic solutions to stop the potential viral contaminants in a sample from the desired product. By using virus removal technique, all the non-enveloped viruses can be completely removed from the sample. The biotherapeutics virus removal filters are basically used during the manufacturing of biotherapeutic drug products or samples such as therapeutic replacement enzymes, antibodies, blood, derivatives of plasma and biopharmaceuticals.

The biotherapeutics virus removal filters can be used either in vivo or in- vitro environment. In biotherapeutics virus removal filtration, the virus removability is based on size-exclusion mechanism that is those viruses which are superior to the mean pore size, they became trapped.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6054

Biotherapeutics Virus removal filters Market: Drivers and Restrains

The global biotherapeutics virus removal filters market is anticipated to register a significant CAGR over a forecast period. The pre-determined risk of contamination in biotherapeutic products is the major factor that can upsurge the growth of the biotherapeutics virus removal filters market.

The global market of biotherapeutics virus removal filters market is driven by the increasing investments in research sector by government. The lack of experience and less awareness can be the factors which can hamper the growth of the market of biotherapeutics virus removal filters.

Biotherapeutics Virus removal filters Market: Regional overview

On the basis of geography, biotherapeutics virus removal filters market is segmented as North America, Latin America, Western Europe, Eastern Europe, Japan, Asia-Pacific and Middle East & Africa. North America is expected to dominate the biotherapeutics virus removal filters market due to the advent of advanced technologies in this region.

Europe is also contributing the moderate shares to the market due to the advanced medical facilities and easy availability of the biotherapeutics virus removal filters in the market. APAC is the most lucrative market for the biotherapeutics virus removal filters due to increasing research facilities and developing biopharmaceutical industry in the region is expected to show a robust growth to the global biotherapeutics virus removal filters market.

MEA is at a nascent stage to the global biotherapeutics virus removal filters market and anticipated to register a decent growth to the market over a forecast period. Overall, the global biotherapeutics virus removal filters market is expected to show significant growth over a forecast period.

Biotherapeutics Virus removal filters Market: Key Players

Some of the major players in the market are Pall Corporation, Z-Medica, LLC, Asahi Kasei Corporation, Merck KGaA, Sartorius AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6054

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Biotherapeutics Virus removal filters Market: Segmentation

The biotherapeutics virus removal filters market is classified into technology, application and end users.

Biotherapeutics Virus removal filters Market is segmented, by Technology –

  • Size Exclusion Technology
  • Depth Filtration Technology

Biotherapeutics Virus removal filters Market is segmented, by Application –

  • Monoclonal Antibodies
  • Blood & Plasma
  • Enzymes
  • Proteins

Biotherapeutics Virus removal filters Market segmented, by End User-

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Institutes
  • Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6054

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Sealants Market is set to increase at a 4.7% CAGR in terms of volume, reaching US$ 680.0 Mn in 2022 | FMI

Dental Sealants Market Analysis and Segment Forecasts To 2022, provides an in-depth analysis of the global dental sealants market with segmentation based on  Product, End User & Region.

NEWARK, Del., April 29, 2022 /PRNewswire/ — As per Future Market Insights’ latest revised industry analysis, the global dental sealants market is projected to reach a valuation of US$ 680 Million in 2022, likely to surge at a vigorous 4.7% CAGR between 2022 – 2032.

Demand in the market is slated to surge on the back of rising awareness and necessity for oral hygiene and dental care. In addition to this, high prevalence of lifestyle-associated dental disorders is underpinning the need for technologically advanced dental equipment, which is expected to boost the market

Dental sealants are thin plastic coatings that are applied to the chewing (occlusal) surfaces of permanent teeth (molars and premolars) to prevent decay. Molar and premolar teeth have grooves or “fissures” on their chewing surfaces decay with time. These cracks can be deep, difficult to clean, and even smaller than a single toothbrush bristle. Dental sealants give added protection to grooved and pitted areas by covering the fissured area with a smooth surface.

Request a Sample to Obtain Authentic Analysis and Comprehensive Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14552

Rising disposable income in developing economies is fueling the preference for aesthetical and cosmetic dentistry. With the trend of beauty and wellness building interest among the general population, advancements in dental adhesives and sealants are gaining traction to secure patient or customer satisfaction.

Moreover, high prevalence of common oral diseases such as dental caries of permanent teeth is propelling sales in the market. With unhealthy lifestyles and dietary habits, the prevalence is expected to increase in the forthcoming years. High sugar intake, caffeine and smoking are the major causes of tooth decay and caries.

Rising government initiatives and investments in providing oral healthcare and awareness are anticipated to fuel sales in the market. The presence of favorable healthcare reimbursement policies in various countries will augment the growth in the market over the forecast period.

“Increasing preference for dental cosmetic procedures, along with technological advancements in materials used in dental procedures will create opportunities for growth in the forthcoming years,” says an FMI analyst.

Leading Companies Profiled in Dental Sealants Market are:

  • 3M
  • Dentsply Sirona
  • PULPDENT Corporation
  • SHOFU Dental GmbH
  • Den-Mat Holdings, LLC
  • Centrix, Inc
  • GC America Inc.
  • Henkel AG & Co. KGaA
  • Dux Industries, Inc.
  • Johnson Services, Inc.
  • Procter & Gamble
  • GlaxoSmithKline plc.

Key Takeaways:

  • By product, the glass ionomer segment is forecast to account for 56.6% of the total market share by 2032, with sales growing at a 3.9% CAGR.
  • In terms of end user, sales in the hospitals held 44.4% of the total market share in 2021, and the trend is expected to continue over the forecast period.
  • Germany will emerge as a lucrative pocket in the Europe dental sealants market, with demand growing at a 4.5% CAGR through 2032.
  • China is expected to account for a lion’s share of the East Asia dental sealants market, with sales projected to increase at a 8.7% CAGR.
  • The U.S. will dominate the North America dental sealants market. Total sales in the North America market will account for 30.4% of the total market share.

Feel Free to Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14552

Competition Landscape

Key players operating in the dental sealants market are investing in product portfolio expansion to gain a competitive edge in the market. Leading players are also investing in acquisitions and partnerships to expand their global footprint. For instance:

  • In December 2021, Nobel Biocare announced the U.S. FDA clearance of the company’s N1™ implant system. This implant system signifies a noteworthy step in advancing toward patient-centric implant solutions.
  • In February 2022, GSK announced its independent consumer healthcare company to be called Haleon.

Key Market Segments Covered In Dental Sealants Industry Research

By Product:

  • Glass Ionomer
  • Polyacid Modified Resin

By End-User:

  • Hospitals
  • Dental Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Over-The-Counter (OTC) Veterinary Drugs Market projected to expand at a CAGR of 8.1% 2022-2032

Global Over-The-Counter (OTC) Veterinary Drugs market is expected to grow at a decent rate owing it to the increase in number of manufacturers for Over-The-Counter (OTC) veterinary drugs, worldwide. There are variety of drugs available in the market as Over-The-Counter (OTC) veterinary drugs for the safe use in animals. These drugs are available in various forms, topical drugs are available as gels, oils, creams, and sprays for various applications. Antibiotics and non-steroidal anti-inflammatory drugs are very common Over-The-Counter (OTC) veterinary drugs in the market. The drugs are available for various medical conditions related with the skin, eyes, and allergic reactions to the animals.

The Over-The-Counter (OTC) veterinary drugs market is well equipped with the retail pharmacies by the end user segment. Injectable drug involve vaccines, which are majorly used by the companion animals for their safety and improving their well-being. The Over-The-Counter (OTC) veterinary drugs market is expected to propel during the forecast period with the growing awareness on the safety and prevention of diseases among companion animals.

Over-The-Counter (OTC) Veterinary Drugs, also termed as non-prescription drugs are drugs that are available without any prescription. These drugs are effective and safe when all the directions on the label or directed by the healthcare professional are followed. The FDA in the U.S. considers when a specific drug is effective and safe enough to be sold over-the-counter. Over-the-counter (OTC) veterinary drugs usage is attributable to the savings on cost incurred on clinical visit and on the drug cost. There are limited veterinary drugs that are approved and available to veterinarians.

Request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9190

The veterinarians often depend on the use of different sources and types of drugs to treat their patients. Over-The-Counter (OTC) veterinary drugs are checked on the assurance of the product effectiveness, safety, and manufacturing to stringent standards for purity, quality, and potency. The FDA Centre for Veterinary Medicine (CVM) is responsible for the manufacturing and distribution of veterinary food additives and drugs. Over-The-Counter (OTC) veterinary drugs are regulated under The Federal Food, Cosmetic, and Drug ACT, which regulated statutory provisions that govern all the key regulations of Over-The-Counter (OTC) veterinary drugs. The Act formulate drugs as, “articles for use in the cure, diagnosis, treatment, mitigation, or prevention of diseases in animals or man”.

Over-The-Counter (OTC) Veterinary Drugs Market: Drivers and Restraints-

Over-The-Counter (OTC) Veterinary Drugs are poised to witness a significant growth owing it to the paradigm shift from Rx to OTC by major pharmaceutical manufacturers. Increasing tendency of people towards the health of their companion animals in developed regions, majorly, and immense cost savings with Over-The-Counter (OTC) veterinary drugs pose various advantages, further boosting demand for Over-The-Counter (OTC) veterinary drugs.

However, several serious issues with OTC drugs pertaining to inappropriate substance abuse vehemently and diagnosis of the animal might obstruct market growth for Over-The-Counter (OTC) veterinary drugs during the forecast timeframe. This has also resulted in withdrawal of various Over-The-Counter (OTC) veterinary drugs used for therapy from the market over the years. Stringent regulations regarding Over-The-Counter (OTC) veterinary drugs and substance abuse related issues might also hinder market growth for Over-The-Counter (OTC) veterinary drugs during the forecast period.

Over-The-Counter (OTC) Veterinary Drugs Market: Region-wise Outlook

Over-The-Counter (OTC) veterinary drugs market is immensely concentrated in major developed economies like the U.S., Japan, and China. The United States is expected to witness a moderate growth due to market saturation in a few product categories. Technological advancements is however, expected to boost market growth for Over-The-Counter (OTC) veterinary drugs worldwide.

Increase in consumer appetite for Over-The-Counter (OTC) veterinary drugs for their companion animals, and growing need of curbing the veterinary-related healthcare costs is expected to fuel the market growth for Over-The-Counter (OTC) veterinary drugs in the Europe region. Increase in efforts for Over-The-Counter (OTC) veterinary drugs licensing for treatment of various diseases in animals is also expected to boost the market growth for Over-The-Counter (OTC) veterinary drugs during the forecast period. However, traditional medications for veterinary disease treatment might slow down the market growth for Over-The-Counter (OTC) veterinary drugs in the Asia-Pacific and MEA region.

Over-The-Counter (OTC) Veterinary Drugs Market: Key Market Participants

Some of the market participants in the Global Over-The-Counter (OTC) Veterinary Drugs market identified across the value chain include: Merck & Co., Inc., Zoetis, Inc., Eli Lilly and Company, Virbac, Bayer AG, Sanofi, Vetoquinol S.A., Boehringer Ingelheim International GmbH, and Dechra Pharmaceuticals PLC.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9190

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Over-The-Counter (OTC) Veterinary Drugs Market: Segmentation

On the basis of Drug Class, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • H2 Receptor Antagonists
  • Non-steroidal Anti-inflammatory Drug
  • Artificial Tears and Ocular Lubricants
  • Antihistamine
  • Antibacterial
  • Glucocorticosteroid
  • Antidiarrheal Agents
  • Nutraceuticals
  • Others

On the basis of Form, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • Topical
  • Oral
  • Injectable

On the basis of Distribution Channel, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • Retail Pharmacies
  • Mail-order Pharmacies
  • Hypermarkets & Supermarkets

On the basis of geography, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

  • North- America
  • Eastern Europe
  • Western Europe
  • Asia-Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa
  • Latin America

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9190

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs